São Paulo, April 23, 2019 – Registrations are open until June 21 for Eurofarma Synapsis, acceleration program with startups intended to leverage businesses that impact on the society by means of innovative solutions in health area. Those interested may register on www.eurofarmasynapsis.com.br.
In its second edition, the program will select 8 scale-ups, that is, solutions already validated and available to the market, with high growth potential. “Our first experience was a success. We made seven pilot projects and closed contract with 4 accelerated companies. We will certainly repeat or increment this partnership”, comments Marco Billi, Corporate Venture and New Businesses manager.
Companies interested in participating must have solutions that will contribute to the improvement of processes and efficiency in health chain productivity, with focus on:
- Business Intelligence
- Shared Services Center
- Commercial and Marketing
- Industrial Operations
Endeavor will be responsible for the scale-ups capture and selection. The companies will be assessed by a multidisciplinary team that will analyze the profile of the entrepreneur and the team involved, level of innovation and the business model and impact. “We are aware of the importance of programs like this to the ecosystem. The connection among large companies and entrepreneurs that are growing contributes to both sides, since these entrepreneurs face many challenges throughout their journey and value the power of connections provided by Eurofarma Synapsis for their growth”, states Luis Felipe Franco, Endeavor’s head of acceleration.
“The companies selected will be accelerated for 7 months, with Endeavor mentoring, and can leverage their business with the sector information and trends, coaching in support areas, like Marketing, Sales and Logistics, and access to Eurofarma network of relationships. It amounts to over 4 thousand suppliers, over 1,500 active clients (B2B), almost 600 thousand medical contacts per month and presence with health products and services in 20 Latin American countries. Eurofarma defined that innovation and sustainability should permeate all areas and processes of the organization. With that, participating in this ecosystem, identifying opportunities and incorporating new technologies is one of the ways we found to follow the goals described in our Strategic Plan. We seek entrepreneurs with this same profile: innovative, sustainable and partners, and want to effectively generate businesses with them”, concludes Maria del Pilar Muñoz, Sustainability & New Businesses vice-president.
Further details can be obtained on www.eurofarmasynapsis.com.br
About Eurofarma Group
Eurofarma Group is a health company, focused on offering products and services to improve the lives of people with quality, innovation and fair price in medical prescription, over-the-counter, generic, hospital, oncology and veterinary areas. In Brazil alone, the company offers 287 products with 622 presentations, serves 30 medical specialties and covers 101 therapeutic classes, which represent 89% of the pharmaceutical retail’s sales.
Founded in 1972 and first multinational pharmaceutical with 100% Brazilian capital, it counts on own operation in 20 countries, keeping an important industrial park in Brazil and plants in other 6 Latin American countries. In 2018, the group generated R$ 4.3 billion in sales and employs over 6.7 thousand collaborators.
Information to the Press
G&A – Relações Públicas
André Pascowitch – 11 5090-8600 r.8369 – firstname.lastname@example.org
Guilherme Gaspar – 11 3065-3045 – email@example.com
Endeavor is one of the main nonprofit organizations for support to entrepreneurs worldwide. It works on the mobilization of public and private organizations and sharing of practical knowledge and examples of high impact entrepreneurs to strengthen the entrepreneur culture in the country.
In Brazil since 2000, it has already helped generate almost R$ 4 billion in revenue annually and over 20,000 direct jobs through entrepreneurs’ support programs. It also promotes an environment that encourages growth and entrepreneurs’ impact ahead of scale-ups, high growth companies with scalable and innovative model.
Information to the Press
Amanda Freitas – 11 95232-1204 – firstname.lastname@example.org